#8: NewsBot: DOR BioPharma Acquires Option for Third-Generation Anthrax Vaccine From Harvard University
DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the
"Company"), a... |
May 8, 2008
02:28:02 PM |
#7: NewsBot: DORB News CORRECTING and REPLACING DOR BioPharma Awarded Two Grants Totaling $5.3 Million to Advance Ricin Toxin and Botulinum Toxin Vaccine Programs
MIAMI--(BUSINESS WIRE)--Reissuing release to correct ticker symbol for searching... |
September 29, 2006
06:08:00 AM |
#6: NewsBot: DORB News Wall Street Advisor Initiates Coverage on DOR BioPharma, Inc. with a Speculative Buy Recommendation
NEW YORK--(BUSINESS WIRE)--Wall Street Advisor has initiated coverage of DOR... |
September 28, 2006
05:00:00 AM |
#5: NewsBot: DORB News DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD; First GI-Directed Therapy to Treat the Most Common Life Threatening Complication of Hematopoietic Stem Cell Transplantation
MIAMI--(BUSINESS WIRE)--Sept. 22, 2006--DOR BioPharma, Inc. (OTCBB: DORB) ("DOR"... |
September 22, 2006
04:00:00 AM |
#4: NewsBot: DORB News DOR BioPharma Announces the Appointment of Christopher J. Schaber, Ph.D. as its new President and Chief Executive Officer and Changes in its Board of Directors
MIAMI--(BUSINESS WIRE)--Aug. 30, 2006--DOR BioPharma, Inc. (OTCBB:DORB) ("DOR" or... |
August 30, 2006
12:04:00 PM |
#3: NewsBot: DORB News DOR BioPharma, Inc. Reports Second Quarter 2006 Financial Results and Reviews Achievements
MIAMI--(BUSINESS WIRE)--Aug. 14, 2006--DOR BioPharma, Inc. (OTCBB:DORB) ("DOR" or... |
August 14, 2006
01:15:00 PM |
#2: NewsBot: DORB News DOR BioPharma Announces Successful Completion of cGMP Production Milestone for RiVax(TM)
MIAMI--(BUSINESS WIRE)--July 6, 2006--DOR BioPharma, Inc. (OTCBB:DORB) ("DOR" or... |
July 6, 2006
06:25:00 AM |
#1: NewsBot: DORB News CORRECTING and REPLACING DOR BioPharma Provides Regulatory Update on orBec
MIAMI--(BUSINESS WIRE)--June 30, 2006--Reissuing release to correct ticker symbol... |
June 30, 2006
01:08:00 PM |
| 
| 
| 
| 
| 
| 
